The Inceptiv data give Medtronic more evidence as it tries to increase sales of a product that drove double-digit growth at ...

Medtronic (NYSE: MDT) today announced 12-month data demonstrating the benefits of its Inceptiv closed-loop spinal cord stimulator (CL-SCS).

Still, Medtronic executives have said their new device, called Inceptiv, is a game changer that they expect to “revolutionize ...

Multiple FDA-approved SCS systems, such as Nevro’s Senza and HFX iQ, as well as Medtronic’s Vanta, Intellis, and Inceptiv systems are available, each offering different features to cater to individual ...

While deep-brain stimulation therapy has been available for people with Parkinson’s disease for decades, Medtronic has now ...

A range of spinal cord stimulators have been approved by the FDA, but none specifically for SCI patients. Abbott, Medtronic and Boston Scientific all have products indicated for chronic pain.

From device clearances to mergers, here are five developments from spine and orthopedic devicemakers since Jan. 8.

Dr. Greg Vigna Spinal cord stimulators are linked to over 80,000 injuries, with lead migration and hematomas causing severe harm <b ...

Competitive analysis and profiles of the major players in the spinal cord stimulation devices market such as Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, Nevro Corporation, ...

Medtronic plc’s MDT strength in the Cardiovascular ... the market is gaining from the continued launch of the Inceptiv closed-loop spinal cord stimulator. In brain stim, Percept RC with ...

The Inceptiv spinal cord stimulation system. [Image courtesy of Medtronic] Medtronic (NYSE: MDT) + today announced 12-month data demonstrating the benefits of its Inceptiv closed-loop spinal cord ...